Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Hematologic malignancy

Differing Outcomes of Patients with High Hyperdiploidy and ETV6-RUNX1 Rearrangement in Korean Pediatric Precursor B Cell Acute Lymphoblastic Leukemia

Jae Wook Lee, Seongkoo Kim, Pil-Sang Jang, Nack-Gyun Chung, Bin Cho

Cancer Res Treat. 2021;53(2):567-575. Published online October 8, 2020 DOI: https://doi.org/10.4143/crt.2020.507

Lymphoma

Prognostic Impact of Age at the Time of Diagnosis in Korean Patients with Diffuse Large B-cell Lymphoma in the Rituximab Era: A Single Institution Study

Hee Sang Hwang, Meejeong Kim, Chan-Sik Park, Dok Hyun Yoon, Cheolwon Suh, Jooryung Huh, Heounjeong Go

Cancer Res Treat. 2021;53(1):270-278. Published online September 15, 2020 DOI: https://doi.org/10.4143/crt.2020.626

Crohn’s Disease Following Rituximab Treatment for Follicular Lymphoma in a Patient with Synchronous Gastric Signet Ring Cells Carcinoma: A Case Report and Literature Review

Elisabetta Cavalcanti, Raffaele Armentano, Ivan Lolli

Cancer Res Treat. 2020;52(4):1291-1295. Published online July 13, 2020 DOI: https://doi.org/10.4143/crt.2020.406

Cited By 1

Lymphoma

Forkhead Box C1 (FOXC1) Expression in Stromal Cells within the Microenvironment of T and NK Cell Lymphomas: Association with Tumor Dormancy and Activation

Ji Hae Nahm, Woo Ick Yang, Sun Och Yoon

Cancer Res Treat. 2020;52(4):1273-1282. Published online July 3, 2020 DOI: https://doi.org/10.4143/crt.2020.032

Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database

Jin Seok Kim, Yanfang Liu, Kyoung Hwa Ha, Hong Qiu, Lee Anne Rothwell, Hyeon Chang Kim

Cancer Res Treat. 2020;52(4):1262-1272. Published online May 4, 2020 DOI: https://doi.org/10.4143/crt.2020.089

A Modified NHL-BFM-95 Regimen Produces Better Outcome Than HyperCVAD in Adult Patients with T-Lymphoblastic Lymphoma, a Two-Institution Experience

Chun Li, Zhi-Jun Wuxiao, Xiaoqin Chen, Guanjun Chen, Yue Lu, Zhongjun Xia, Yang Liang, Hua Wang

Cancer Res Treat. 2020;52(2):573-585. Published online December 6, 2019 DOI: https://doi.org/10.4143/crt.2019.542

Cited By 1

Detection of Targetable Genetic Alterations in Korean Lung Cancer Patients: A Comparison Study of Single-Gene Assays and Targeted Next-Generation Sequencing

Eunhyang Park, Hyo Sup Shim

Cancer Res Treat. 2020;52(2):543-551. Published online November 8, 2019 DOI: https://doi.org/10.4143/crt.2019.305

Cited By 3

Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30–Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial

Seok Jin Kim, Dok Hyun Yoon, Jin Seok Kim, Hye Jin Kang, Hye Won Lee, Hyeon-Seok Eom, Jung Yong Hong, Junhun Cho, Young Hyeh Ko, Jooryung Huh, Woo-Ick Yang, Weon Seo Park, Seung-Sook Lee, Cheolwon Suh, Won Seog Kim

Cancer Res Treat. 2020;52(2):374-387. Published online August 13, 2019 DOI: https://doi.org/10.4143/crt.2019.198

Cited By 5

Clinical Characteristics and Treatment Outcomes of Pediatric Patients with Non-Hodgkin Lymphoma in East Asia

Jin Kyung Suh, Yi-Jin Gao, Jing-Yan Tang, Shiann-Tarng Jou, Dong-Tsamn Lin, Yoshiyuki Takahashi, Seiji Kojima, Ling Jin, Yonghong Zhang, Jong Jin Seo

Cancer Res Treat. 2020;52(2):359-368. Published online July 29, 2019 DOI: https://doi.org/10.4143/crt.2019.219

Diffuse Large B-Cell Lymphoma Arising within Ileal Neobladder: An Expanding Spectrum of Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation

Hyekyung Lee, Hyunbin Shin, Nae Yu Kim, Hyun Sik Park, Jinsung Park

Cancer Res Treat. 2019;51(4):1666-1670. Published online March 22, 2019 DOI: https://doi.org/10.4143/crt.2019.022

Characteristics, Prognostic Factors, and Survival of Patients with NK/T-Cell Lymphoma of Non-upper Aerodigestive Tract: A 17-Year Single-Center Experience

Ze-Long Liu, Xi-Wen Bi, Xue-Wen Zhang, De-Xin Lei, Pan-Pan Liu, Hang Yang, Yan Gao, Yuan-Xue Jiang, Wen-Qi Jiang, Yi Xia

Cancer Res Treat. 2019;51(4):1557-1567. Published online April 1, 2019 DOI: https://doi.org/10.4143/crt.2018.681

Prognostic Value of Baseline and Interim Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT in Patients with Follicular Lymphoma

Jin-Hua Liang, Yun-Ping Zhang, Jun Xia, Chong-Yang Ding, Wei Wu, Li Wang, Lei Cao, Hua-Yuan Zhu, Lei Fan, Tian-Nv Li, Jian-Yong Li, Wei Xu

Cancer Res Treat. 2019;51(4):1479-1487. Published online March 12, 2019 DOI: https://doi.org/10.4143/crt.2018.649

Cited By 2

Body Cavity–Based Lymphoma in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of Lymphoma

Junghoon Shin, Young Hyeh Ko, Sung Yong Oh, Dok Hyun Yoon, Jeong-Ok Lee, Jin Seok Kim, Yong Park, Ho Jin Shin, Seok Jin Kim, Jong Ho Won, Sung-Soo Yoon, Won Seog Kim, Youngil Koh, On behalf of the Consortium for Improving Survival of Lymphoma investigators

Cancer Res Treat. 2019;51(4):1302-1312. Published online February 14, 2019 DOI: https://doi.org/10.4143/crt.2018.555

Cited By 3

Alterations in PD-L1 Expression Associated with Acquisition of Resistance to ALK Inhibitors in ALK-Rearranged Lung Cancer

Su-Jung Kim, Soyeon Kim, Dong-Wan Kim, Miso Kim, Bhumsuk Keam, Tae Min Kim, Yusoo Lee, Jaemoon Koh, Yoon Kyung Jeon, Dae Seog Heo

Cancer Res Treat. 2019;51(3):1231-1240. Published online December 31, 2018 DOI: https://doi.org/10.4143/crt.2018.486

Cited By 7

Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial

Xueying Li, He Huang, Bing Xu, Hongqiang Guo, Yingcheng Lin, Sheng Ye, Jiqun Yi, Wenyu Li, Xiangyuan Wu, Wei Wang, Hongyu Zhan, Derong Xie, Jiewen Peng, Yabing Cao, Xingxiang Pu, Chengcheng Guo, Huangming Hong, Zhao Wang, Xiaojie Fang, Yong Zhou, Suxia Lin, Qing Liu, Tongyu Lin

Cancer Res Treat. 2019;51(3):919-932. Published online October 2, 2018 DOI: https://doi.org/10.4143/crt.2018.230

Cited By 5

Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas

Seok-Jin Kim, Jiyeon Hyeon, Inju Cho, Young Hyeh Ko, Won Seog Kim

Cancer Res Treat. 2019;51(2):611-622. Published online July 20, 2018 DOI: https://doi.org/10.4143/crt.2018.191

Cited By 23

Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular Lymphoma

Hansang Lee, Dongryul Oh, Kyungmi Yang, Young Hyeh Ko, Yong Chan Ahn, Won Seog Kim, Seok Jin Kim

Cancer Res Treat. 2019;51(2):547-555. Published online July 10, 2018 DOI: https://doi.org/10.4143/crt.2018.190

Cited By 4

Circulating Low Absolute CD4⁺ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy

Ya-Ping Zhang, Run Zhang, Hua-Yuan Zhu, Li Wang, Yu-Jie Wu, Jin-Hua Liang, Wen-Yu Shi, Hong Liu, Wei Xu, Jian-Yong Li

Cancer Res Treat. 2019;51(1):368-377. Published online May 14, 2018 DOI: https://doi.org/10.4143/crt.2018.010

Cited By 2

The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH

Jin-Hua Liang, Luo Lu, Hua-Yuan Zhu, Wang Li, Lei Fan, Jian-Yong Li, Wei Xu

Cancer Res Treat. 2019;51(1):150-157. Published online April 2, 2018 DOI: https://doi.org/10.4143/crt.2017.476

Cited By 4

Delayed Terminal Ileal Perforation in a Relapsed/Refractory B-Cell Lymphoma Patient with Rapid Remission Following Chimeric Antigen Receptor T-Cell Therapy

Yongxian Hu, Jiasheng Wang, Chengfei Pu, Kui Zhao, Qu Cui, Guoqing Wei, Wenjun Wu, Lei Xiao, Yang Xiao, Jinping Wang, Zhao Wu, He Huang

Cancer Res Treat. 2018;50(4):1462-1466. Published online February 5, 2018 DOI: https://doi.org/10.4143/crt.2017.473

Cited By 6

HBsAg-Negative, Anti-HBc–Negative Patients Still Have a Risk of Hepatitis B Virus–Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma

Hyunsung Park, Do Young Kim, Soo-Jeong Kim, Haerim Chung, Hyunsoo Cho, Ji Eun Jang, June-Won Cheong, Yoo Hong Min, Jae-Woo Song, Jin Seok Kim

Cancer Res Treat. 2018;50(4):1121-1129. Published online December 4, 2017 DOI: https://doi.org/10.4143/crt.2017.329

Cited By 1

Danbee Kang, Juhee Cho, Im Ryung Kim, Mi Kyung Kim, Won Seog Kim, Seok Jin Kim

Cancer Res Treat. 2018;50(4):1051-1063. Published online November 9, 2017 DOI: https://doi.org/10.4143/crt.2017.207

Cited By 6

Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type

Hyun Jee Kim, Chan-Young Ock, Tae Min Kim, Sung Hee Lee, Ju-Yeun Lee, Sun hoi Jung, Yoon Sook Cho, Miso Kim, Bhumsuk Keam, Dong-Wan Kim, Il Han Kim, Dae Seog Heo

Cancer Res Treat. 2018;50(3):670-680. Published online July 3, 2017 DOI: https://doi.org/10.4143/crt.2017.051

Cited By 4

Crizotinib in Combination with Everolimus Synergistically Inhibits Proliferation of Anaplastic Lymphoma Kinase‒Positive Anaplastic Large Cell Lymphoma

Wendan Xu, Ji-Won Kim, Woo June Jung, Youngil Koh, Sung-Soo Yoon

Cancer Res Treat. 2018;50(2):599-613. Published online June 19, 2017 DOI: https://doi.org/10.4143/crt.2016.357

Cited By 2

Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01

Jung Hye Choi, Tae Min Kim, Hyo Jung Kim, Sung Ae Koh, Yeung-Chul Mun, Hye Jin Kang, Yun Hwa Jung, Hyeok Shim, So Young Chong, Der-Sheng Sun, Soonil Lee, Byeong Bae Park, Jung Hye Kwon, Seung-Hyun Nam, Jun Ho Yi, Young Jin Yuh, Jong-Youl Jin, Jae Joon Han, Seok-Hyun Kim

Cancer Res Treat. 2018;50(2):590-598. Published online June 9, 2017 DOI: https://doi.org/10.4143/crt.2017.172

Cited By 3

Low-Dose Radiation Therapy for Primary Conjunctival Marginal Zone B-Cell Lymphoma

Ga-In Lee, Dongryul Oh, Won Seog Kim, Seok Jin Kim, Young Hyeh Ko, Kyung In Woo, Yoon-Duck Kim, Yong Chan Ahn

Cancer Res Treat. 2018;50(2):575-581. Published online June 16, 2017 DOI: https://doi.org/10.4143/crt.2017.182

Cited By 8

ALK Protein Expression Is Related to Neuroblastoma Aggressiveness But Is Not Independent Prognostic Factor

Ji Won Lee, Sung Hye Park, Hyoung Jin Kang, Kyung Duk Park, Hee Young Shin, Hyo Seop Ahn

Cancer Res Treat. 2018;50(2):495-505. Published online May 22, 2017 DOI: https://doi.org/10.4143/crt.2016.577

Cited By 3

Validation of the Korean Version of the Quality of Life–Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors

Juhee Cho, Danbee Kang, Im Ryung Kim, Won Seog Kim, Betty Ferrell, Seok Jin Kim

Cancer Res Treat. 2018;50(1):204-211. Published online March 30, 2017 DOI: https://doi.org/10.4143/crt.2017.091

Cited By 4

Human Herpesvirus 8–Unrelated Primary Effusion Lymphoma–Like Lymphoma in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone

Junghoon Shin, Jeong-Ok Lee, Ji-Young Choe, Soo-Mee Bang, Jong-Seok Lee

Cancer Res Treat. 2017;49(1):274-278. Published online June 10, 2016 DOI: https://doi.org/10.4143/crt.2016.076

Cited By 4

Comparison of Total Body Irradiation (TBI) Conditioning with Non-TBI for Autologous Stem Cell Transplantation in Newly Diagnosed or Relapsed Mature T- and NK-Cell Non-Hodgkin Lymphoma

Chi Hoon Maeng, Young Hyeh Ko, Do Hoon Lim, Eun Suk Kang, Joon Young Choi, Won Seog Kim, Seok Jin Kim

Cancer Res Treat. 2017;49(1):92-103. Published online May 9, 2016 DOI: https://doi.org/10.4143/crt.2015.476

Cited By 1